On 17 November Celldex Therapeutics, Inc. (NASDAQ:CLDX) provided an interim update from its Phase 2 study of rindopepimut in EGFRvIII-positive glioblastoma. The results demonstrated clear signs of clinical activity. Celldex Therapeutics, Inc. (NASDAQ:CLDX) in last trading activity decreased -2.90% to close at $17.72. Company weekly performance is 22.54% while its quarterly performance stands at 17.27%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is -46.83% away from its 52 week high.
Groupon, Inc. (NASDAQ:GRPN) announced that it has acquired Swarm Mobile, a startup that helps businesses connect with and track their customers while in stores. On last trading day Groupon, Inc. (NASDAQ:GRPN) decreased -2.64% to close at $7.37. Its volatility for the week is 5.07% while volatility for the month is 5.37%. Groupon, Inc. (NASDAQ:GRPN) monthly performance is 18.68%.
On 29 October Compugen Ltd. (NASDAQ:CGEN) reported financial results for the third quarter and nine months ending September 30, 2014. Revenues for the third quarter of 2014 were $1.7 million, compared with $1.6 million in the third quarter of 2013. Net loss for the third quarter of 2014 was $5.4 million, or $0.11 per diluted share, compared with a net loss of $4.7 million, or $0.12 per diluted share, in the comparable period in 2013. On last trading day Compugen Ltd. (NASDAQ:CGEN) moved up 0.62% to close at $6.48. Its volatility for the week is 4.51% while volatility for the month is 4.40%. CGEN’s sales growth for past 5 years was 63.50% and its EPS growth for past 5 years was 3.90%. Compugen Ltd. (NASDAQ:CGEN) monthly performance is -15.84%.
Tremor Video, Inc. (NYSE:TRMR) was upgraded by Jefferies Group from a “hold” rating to a “buy” rating in a research note issued on Tuesday. Tremor Video, Inc. (NYSE:TRMR) has 0.40% insider ownership while its institutional ownership stands at 71.70%. In last trading activity company’s stock closed at $2.57.
BCB Bancorp Inc. (NASDAQ:BCBP) Director James Edward Collins bought 2,306 shares of the company’s stock in a transaction that occurred on Wednesday, October 29th. The shares were purchased at an average price of $12.76 per share, with a total value of $29,424.56. Following the purchase, the director now directly owns 81,878 shares in the company, valued at approximately $1,044,763. On Tuesday shares of BCB Bancorp Inc. (NASDAQ:BCBP) closed at $12.39. Company’s sales growth for last 5 years was 9.40%